Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

269
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

289
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
289
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

191
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
191
What is the Immune System?01:38

What is the Immune System?

131.2K
Overview
131.2K
The Extracellular Matrix01:42

The Extracellular Matrix

89.3K
Overview
89.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TopoMetry systematically learns and evaluates the latent geometry of single-cell data.

eLife·2026
Same author

Sympathetic NPY signaling at the crossroads of neuro-tumoral metabolism.

Cell metabolism·2026
Same author

Human-derived cardiac-neural microtissues reveal catecholaminergic polymorphic ventricular tachycardia is also a disease of the sympathetic neuron.

The Journal of physiology·2026
Same author

Semaglutide mitigates the loss of fat-free mass and decreased energy expenditure observed after diet restriction. Insights from an obese minipig model.

American journal of physiology. Endocrinology and metabolism·2026
Same author

Neuroimmunometabolism in Health and Disease.

Annual review of immunology·2026
Same author

Class A scavenger receptor MARCO negatively regulates Ace expression and aldosterone production.

eLife·2025

Related Experiment Video

Updated: Feb 10, 2026

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

26.0K

Macrophages in obesity.

Roksana M Pirzgalska1, Ana I Domingos2

  • 1Obesity Laboratory, Instituto Gulbenkian de Ciência, Oeiras 2780-156, Portugal.

Cellular Immunology
|May 30, 2018
PubMed
Summary
This summary is machine-generated.

Researchers discovered sympathetic neuron-associated macrophages (SAMs) that reduce obesity by clearing norepinephrine (NE). This neuro-immune interaction offers new therapeutic targets for obesity treatment.

Keywords:
Adipose tissueMacrophagesNeuro-immune interactionsObesitySympathetic neuron-associated macrophages

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K
An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.6K

Related Experiment Videos

Last Updated: Feb 10, 2026

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

26.0K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K
An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.6K

Area of Science:

  • Neuroimmunology
  • Metabolic Diseases
  • Adipose Tissue Biology

Background:

  • Obesity is a global health issue with limited safe treatment options.
  • Sympathetic nervous system activity, mediated by norepinephrine (NE), is crucial for reducing fat mass.
  • The role of macrophages in adipose tissue during obesity onset and their connection to NE signaling remain unclear.

Purpose of the Study:

  • To identify and characterize a novel population of macrophages linked to sympathetic neurons.
  • To investigate the function of these sympathetic neuron-associated macrophages (SAMs) in regulating obesity.
  • To elucidate the neuro-immune mechanisms underlying obesity, focusing on SAMs and adipose tissue macrophages (ATMs).

Main Methods:

  • Identification of a distinct macrophage population associated with sympathetic neurons.
  • Analysis of the genetic, cellular, and functional characteristics of SAMs.
  • Comparison of SAMs with traditional adipose tissue macrophages (ATMs) in the context of obesity.

Main Results:

  • A novel population of sympathetic neuron-associated macrophages (SAMs) was identified.
  • SAMs were found to control obesity by actively taking up and clearing norepinephrine (NE).
  • Distinct signatures differentiate SAMs from ATMs, highlighting specialized roles in neuro-immune regulation.

Conclusions:

  • Sympathetic neuron-associated macrophages (SAMs) represent a key neuro-immune link in metabolic regulation.
  • SAMs' capacity to clear NE positions them as critical regulators of adipose tissue homeostasis and obesity.
  • Understanding SAMs offers potential for developing novel therapeutic strategies targeting neuro-immune pathways for obesity.